5th Wet AMD and Diabetic Eye Disease Drug Summit
-
Location:
- Revere Hotel Boston Common
- 200 Stuart Street
- Boston
- Massachusetts
- 02116
- United States
- View on a map
- More Information:
-
Contact:
- Organiser: Hanson Wade
- Name: Eden Chau
- Email: info@hansonwade.com
Global biopharmaceutical leaders continue to make significant strides in retinal disease treatments; as Bayer and Regeneron make headway with its high-dose version of Eylea (Eylea HD), Roche's Vabysmo is providing strong competition and has rapidly increased its market share across wet AMD and DME.
Additionally, biotechs are pioneering new breakthroughs such as Outlook Therapeutics developing bevacizumab for FDA approval in ophthalmic indications, while Ocular Therapeutix progresses innovative sustained-release drug delivery systems to extend treatment intervals and enhance patient outcomes.
The 2025 Wet AMD and Diabetic Eye Disease Drug Summit is the only industry-led event dedicated to exploring the latest advancements, strategic collaborations, and cutting-edge research driving the field of retinal disease treatment forward.
Join a dynamic community of 70+ global leaders, including translational, clinical, and commercial experts as they gather at this premier summit. Attendees will gain unparalleled insights into emerging therapies, adaptive trial designs, and the latest clinical studies aimed at improving treatment efficacy and patient care.
Date and Time: Tuesday, 18 March 2025 at 08:00 to Thursday, 20 March 2025 at 16:20
